Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bayer CropScience Raises R&D Spending

by Melody M. Bomgardner
September 26, 2011 | A version of this story appeared in Volume 89, Issue 39

Bayer CropScience will phase out some older products, increase R&D spending, and extend its seed business, CEO Sandra E. Peterson told reporters at the firm’s annual press conference. The company will accelerate its previously announced phaseout of aldicarb and all other insecticides listed as Class 1, or hazardous, by the World Health Organization. Bayer will increase spending on crop R&D by 20% to $1.2 billion by 2015, including a doubling of the budget for seed development to $550 million. And the firm plans to expand its seed and traits businesses for cotton, oilseeds, and vegetables.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.